Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for Alcohol Use Disorder
NCT06994338Phase 2Recruiting
- Sponsor
- University of Southern California
- Start
- Oct 2025
- Primary completion
- Aug 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Tirzepatide with Placebo (2 arms). Primary endpoint: Number of heavy drinking days. Started Oct 2025; status: recruiting.
02
Drugs
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06994338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06994338.